You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 11, 2025

IRONWOOD Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for IRONWOOD
International Patents:182
US Patents:9
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for IRONWOOD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ironwood Pharms Inc DUZALLO allopurinol; lesinurad TABLET;ORAL 209203-001 Aug 18, 2017 DISCN Yes No 8,283,369 ⤷  Try for Free ⤷  Try for Free
Ironwood Pharms Inc ZURAMPIC lesinurad TABLET;ORAL 207988-001 Dec 22, 2015 DISCN Yes No 8,003,681 ⤷  Try for Free Y ⤷  Try for Free
Ironwood Pharms Inc DUZALLO allopurinol; lesinurad TABLET;ORAL 209203-002 Aug 18, 2017 DISCN Yes No 8,357,713 ⤷  Try for Free Y ⤷  Try for Free
Ironwood Pharms Inc DUZALLO allopurinol; lesinurad TABLET;ORAL 209203-001 Aug 18, 2017 DISCN Yes No 8,546,436 ⤷  Try for Free Y ⤷  Try for Free
Ironwood Pharms Inc ZURAMPIC lesinurad TABLET;ORAL 207988-001 Dec 22, 2015 DISCN Yes No 10,183,012 ⤷  Try for Free ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for IRONWOOD Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2135608 CA 2016 00034 Denmark ⤷  Try for Free PRODUCT NAME: LESINURAD ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU1/15/1080 20160222
2217577 132019000000023 Italy ⤷  Try for Free PRODUCT NAME: ALLOPURINOLO/LESINURAD, O UN LORO SALE FARMACEUTICAMENTE ACCETTABILE O LORO SALI FARMACEUTICAMENTE ACCETTABILI(DUZALLO); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1300, 20180827
2135608 132016000081719 Italy ⤷  Try for Free PRODUCT NAME: LESINURAD, O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE(ZURAMPIC); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/15/1080, 20160222
2217577 SPC/GB19/006 United Kingdom ⤷  Try for Free PRODUCT NAME: LESINURAD, OR A PHARMACEUTICALLY ACCEPTABLE SALT, OR SALTS THEREOF, AND ALLOPURINOL; REGISTERED: UK EU/1/18/1300/001(NI) 20180827; UK EU/1/18/1300/002(NI) 20180827; UK EU/1/18/1300/003(NI) 20180827; UK EU/1/18/1300/004(NI) 20180827
2135608 1690033-4 Sweden ⤷  Try for Free PRODUCT NAME: LESINURAD, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; REG. NO/DATE: EU/1/15/1080 20160222
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.